Vitamina D y otras enfermedades pulmonares

Suplementacja witaminy D w chorobach płuc. Cz. 3f. Inne choroby płuc
Carolien Mathyssen, Ghislaine Gayan-Ramirez, Roger Bouillon, Wim Janssens

En un metaanálisis realizado recientemente, Martineau y cols. evaluaron los efectos de la suplementación con vitamina D en infecciones agudas de las vías respiratorias (superiores e inferiores). La singularidad de este estudio radica en el hecho de que se realizó en una población de 15000 personas. Se demostró que la administración de suplementos con vitamina D se relaciona con una disminución del riesgo de infecciones de las vías respiratorias en la población general (odds ratio [OR] corregida: 0,88; 95 % IC 0,81-0,96), especialmente si la vitamina D se administró a diario (OR corregida: 0,81; 95 % IC: 0,72-0,91) y particularmente en personas con su déficit (OR corregida: 0,30; 95 % IC: 0,17-0,53).43


1. Baeke F., Takiishi T., Korf H. y cols., Vitamin D: modulator of the immune system, Curr. Opin. Pharmacol., 2010, 10: 482-496.
2. Janssens W., Lehouck A., Carremans C. y cols., Pulmonary Perspective Vitamin D Beyond Bones in Chronic Obstructive Pulmonary Disease Time to Act, Am. J. Respir. Crit. Care Med., 2009, 179: 630-636.
3. Hughes D.A, Norton R., Vitamin D and respiratory health, Cin. Exp. Immunol., 2009, 158: 20-25.
4. Palacios C., Gonzalez L., Is vitamin D deficiency a major global public health problem?, J. Steroid Biochem. Mol. Biol., 2014, 144 (PA), 138-155.
5. Holick M.F., Chen T.C., Vitamin D deficiency. A worldwide problem with health, Am. J. Clin. Nutr., 2008, 87: 1080-1086.
6. Janssens W., Bouillon R., Claes B. y cols., Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene, Thorax, 2010, 65: 215-220.
7. Hejazi M., Modarresi-Ghazani F., Entezari-Maleki T., A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis, J. Res. Pharm. Pract., 2016, 5 (1): 7.
8. Holick M.F., Vitamin D deficiency, N. Engl. J. Med., 2007, 357: 266-281, http: // landingpage& an=00008480-201202000-00008
9. Foong R.E., Zosky G.R., Vitamin D deficiency and the lung: Disease initiator or disease modifier?, Nutrients, 2013, 5 (8): 2880-2900.
10. Chishimba L., Thickett D.R., Stockley R.A. y cols., The vitamin D axis in the lung: a key role for vitamin D-binding protein, Thorax, 2010, 65: 456-462.
11. Bikle D., Vitamin D metabolims, mechanism of action, and clinical applications, Chem. Biol., 2014, 21 (3): 319-329.
12. Hansdottir S., Monick M.M., Hinde S.L. y cols., Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense 1, 2008, 14 (6).
13. Liu P.T., Stenger S., Tang D.H. y cols., Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin, J. Immunol., 2007, 179 (4): 2060-2063.
14. Heulens N., Korf H., Mathyssen C. y cols., 1,25-Dihydroxyvitamin D Modulates Antibacterial and Inflammatory Response in Human Cigarette Smoke-Exposed Macrophages, PLoS One, 2016, 11 (8): e0160482.
15. Zhang Y., Leung D.Y.M., Richers B.N. y cols., Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1, J. Immunol., 2012, 188: 2127-2135.
16. Bouillon R., Comparative analysis of nutritional guidelines for vitamin D, Nat. Rev. Endocrinol., 2017, 13 (8): 466-479, http: // 2017.31
17. Shah S., Chiang C., Sikaris K. y cols., Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease, J. Clin. Endocrinol. Metab., 2017, 102 (September 2016): 2321-2328.
18. Huang S.-J., Wang X.-H., Liu Z.-D. y cols., Vitamin D deficiency and the risk of tuberculosis: a meta-analysis, Drug Des., 2017, 11: 91-102.
19. Talat N., Perry S., Parsonnet J. y cols., Vitamin D deficiency and tuberculosis progression, Emerg. Infect. Dis., 2010, 16 (5): 853-855.
20. Martineau A.R., Timms P.M., Bothamley G.H. y cols., High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial, Lancet, 2011, 377 (9761): 242-250.
21. Boyle M.P., Noschese M.L., Watts S.L. y cols., Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis, Am. J. Respir. Crit. Care Med., 2005, 172 (2): 212-217.
22. Donovan Jr D.S., Papadopoulos A., Staron R.B. y cols., Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease, Am. J. Respir. Crit. Care Med., 1998, 157 (6 Pt 1): 1892-1899.
23. Grey V., Atkinson S., Drury D. y cols., Prevalence of Low Bone Mass and Deficiencies of Vitamins D and K in Pediatric Patients With Cystic Fibrosis From 3 Canadian Centers, Pediatrics, 2008, 122 (5): 1014-1020.
24. Rovner A.J., Stallings V.A., Schall J.I. y cols., Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation, Am. J. Clin. Nutr., 2007, 86 (6): 1694-1699.
25. Stephenson A., Brotherwood M., Robert R. y cols., Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis 1, 2, Am. J. Clin. Nutr., 2007, 85: 1307-1311.
26. Wolfenden L.L., Judd S.E., Shah R. y cols., Vitamin D and bone health in adults with cystic fibrosis, Clin. Endocrinol. (Oxf.), 2008, 69 (3): 374-381.
27. Chavasse R.J., Francis J., Balfour-Lynn I. y cols., Serum vitamin D levels in children with cystic fibrosis, Pediatr. Pulmonol., 2004, 38 (2): 119-122.
28. Bener A., Ehlayel M.S., Bener H.Z. y cols., The impact of Vitamin D deficiency on asthma, allergic rhinitis and wheezing in children. An emerging public health problem, J. Fam. Comm. Med., 2014, 21 (3): 154-161.
29. Hagaman J.T., Panos R.J., McCormack F.X. y cols., Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases, Chest, 2011, 139 (2): 353-360.
30. Muhe L., Lulseged S., Mason K.E. y cols., Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children, Lancet, 1997, 349 (9068): 1801-1804.
31. Jat K.R., Kaur J., Guglani V., Vitamin D and Pneumonia in Children. A Case Control Study, J Pulm. Med. Respir. Res., 2016, 2: 2-5.
32. Roth D.E., Jones B., Prosser C. y cols., Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood, Eur. J. Clin. Nutr., 2009, 63 (2): 297-299.
33. Maclaughlin J., Holick M.F., Aging Decreases the Capacity of Human-Skin to Produce Vitamin-D3, J. Clin. Invest., 1985, 76 (4): 1536-1538.
34. Waldron J.L., Ashby H.L., Cornes M.P. y cols., Vitamin D: a negative acute phase reactant, J. Clin. Pathol., 2013, 66 (7): 620-622.
35. Skversky A.L., Kumar J., Abramowitz M.K. y cols., Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006, J. Clin. Endocrinol. Metab., 2011, 96 (12): 3838-3845.
36. Black P.N., Scragg R., Relationship Between Serum 25- Hydroxyvitamin D and Pulmonary Function in the Third National Health and Nutrition Examination Survey, Chest, 2005, 128 (6): 3792-3798.
37. Afzal S., Lange P., Bojesen S.E. y cols., Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease, Thorax, 2014, 69: 24-31.
38. Lange N.E., Sparrow D., Vokonas P. y cols., Vitamin D deficiency, smoking, and lung function in the Normative Aging Study, Am. J. Respir. Crit. Care Med., 2012, 186: 616-621.
39. Camargo Jr C.A., Rifas-Shiman S.L. Litonjua A.A. y cols., Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age, Am. J. Clin. Nutr., 2007, 85 (6): 788-795.
40. Cao Y., Wang X., Cao Z. y cols., Vitamin D receptor gene FokI polymorphisms and tuberculosis susceptibility. A meta-analysis, Arch. Med. Sci., 2016, 12 (5): 1118-1134.
41. Han J.-C., Du J., Zhang Y.-J. y cols., Vitamin D receptor polymorphisms may contribute to asthma risk, J. Asthma, 2016, 53 (8): 790-800.
42. Tripkovic L., Lambert H., Hart K. y cols., Comparison of vitamin D 2 and vitamin D 3 supplementation in raising serum 25-hydroxyvitamin D status : a systematic review, Am. J. Clin. Nutr., 2012, 95: 1357-1364.
43. Martineau A., Jolliffe D., Hooper R. y cols., Vitamin d supplementation to prevent acute respiratory infections: systematic review and meta-analysis of individual participant data, BMJ, 2017, 356.
44. Green M., Cod liver oil and tuberculosis, BMJ, 2011, 343 (7837): 1305-1307.
45. Morcos M., Gabr A., Samuel S. y cols., Vitamin D administration to tuberculous children and its value, Boll. Chim. Farm., 1998, 137 (5): 157-164.
46. Nursyam E.W., Amin Z., Rumende C.M., The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion, Acta Med. Indones., 2006, 38 (1): 3-5.
47. Salahuddin N., Ali F., Hasan Z. y cols., Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonar, BMC Infect. Dis., 2013, 13 (1): 22.
48. Hassanein E.G., Mohamed E.E., Baess A.I. y cols., The role of supplementary vitamin D in treatment course of pulmonary tuberculosis, Egypt J. Chest Dis. Tuberc., 2016, 65 (3): 629-635.
49. Wejse C., Gomes V.F., Rabna P. y cols., Vitamin D as supplementary treatment for tuberculosis. A double-blind, randomized, placebo-controlled trial, Am. J. Respir. Crit. Care Med., 2009, 179 (9): 843-850.
50. Tukvadze N., Sanikidze E., Kipiani M. y cols., High-dose vitamin D 3 in adults with pulmonary tuberculosis. A double-blind randomized controlled trial, Am. J. Clin. Nuttrition., 2015, 102 (C): 1059-1069.
51. Jingyan X., Liyun S., Lifang Z. y cols., Impact of vitamin D supplementation on the outcome of tuberculosis treatment. A systematic review and meta-analysis of randomized controlled trials, Chin. Med. J. (Engl.), 2014, 127 (17): 3127-3134.
52. Manaseki-Holland S., Qader G., Isaq Masher M. y cols., Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial, Trop. Med. Int. Heal., 2010, 15 (10): 1148-1155.
53. Choudhary N., Gupta P., Vitamin D supplementation for severe pneumonia - a randomized controlled trial, Indian. Pediatr., 2012, 49 (6): 449-454.
54. Rajshekhar C.S., Vanaki R., Badakali A.V. y cols., Efficacy of vitamin D supplementation in the treatment of severe pneumonia in children aged less than five years, Int. J. Contemp. Pediatr., 2016, 3 (1): 96-99.
55. Gupta P., Dewan P., Shah D. y cols., Vitamin D supplementation for treatment and prevention of pneumonia in under-five children. A randomized double-blind placebo controlled trial, Indian Pediatr., 2016, 53 (11): 967-976.
56. OMS, Pneumonia, OMS, 2016.
57. Das R.R., Singh M., Panigrahi I. y cols., Vitamin D Supplementation for the Treatment of Acute Childhood Pneumonia. A Systematic Review, ISRN Pediatr., 2013, 2013: 459160.
58. Lehouck A., Mathieu C., Carremans C. y cols., High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease, Ann. Intern. Med., 2012, 156: 105-114.
59. Martineau A.R., James W.Y., Hooper R.L. y cols., Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial, Lancet Respir. Med., 2015, 3: 120-130.
60. Zendedel A., Gholami M., Anbari K. y cols., Effects of Vitamin D Intake on FEV1 and COPD Exacerbation. A Randomized Clinical Trial Study, Glob. J. Health Sci., 2015, 7 (4): 243-248, http: //
61. Sanjari M., Soltani A., Habibi Khorasani A. y cols., The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial, J. Diabetes Metab. Disord., 2016, 15 (1): 33.
62. Rafiq R., Aleva F.E., Schrumpf J.A. y cols., Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID). A study protocol, BMC Pulm. Med., 2015, 15 (1): 106.
63. Hornikx M., Van Remoortel H., Lehouck A. y cols., Vitamin D supplementation during rehabilitation in COPD. A secondary analysis of a randomized trial, Respir. Res., 2012, 13 (84).
64. Bjerk S.M., Edgington B.D., Rector T.S. y cols., Supplemental vitamin D and physical performance in COPD. A pilot randomized study, Int. J. COPD, 2013, 8: 97-104.
65. Rafiq R., Prins H., Boersma W. y cols., Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients. A pilot trial, Int. J. Chron. Obstruct. Pulmon. Dis., 2017, 2: 2583-2592, https: // stren-peer-reviewed-article-COPD
66. Brown S.A., Ontjes D.A., Lester G.E. y cols., Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis, Osteoporos. Int., 2003, 14 (5): 442-449.
67. Haworth C.S., Jones A.M., Adams J.E. y cols., Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis, J. Cyst. Fibros., 2004, 3 (4): 233-236.
68. Hillman L.S., Cassidy J.T., Popescu M.F. y cols., Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: Effect of supplementation with vitamin D and calcium, Pediat. Pulm., 2008, 43: 772-780.
69. Khazai N.B., Judd S.E., Jeng L. y cols., Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light, J. Clin. Endocrinol. Metab., 2009, 94 (6): 2037-2043.
70. Simoneau T., Sawicki G.S., Milliren C.E. y cols., A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients, J. Cyst. Fibros., 2016, 15 (2): 234-241.
71. Grossmann R.E., Zughaier S.M., Kumari M. y cols., Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation. A randomized, controlled trial, Dermatoendocrinol, 2012, 4 (2): 191-197.
72. Pincikova T., Paquin-Proulx D., Sandberg J.K. y cols., Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial, Eur. J. Clin. Nutr., 2017, 71 (2): 203-205.
73. Grossmann R.E., Zughaier S.M., Liu S. y cols., Impact on vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for apulmonary exacrebation, Eur. J. Clin. Nutr., 2012, 66: 1072-1074.
74. Luo J., Liu D., Liu C.-T., Can Vitamin D Supplementation in Addition to Asthma Controllers Improve Clinical Outcomes in Patients With Asthma?, Medicine (Baltimore), 2015, 94 (50): e2185.
75. Baris S., Kiykim A., Ozen A. y cols., Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite, Allergy Eur. J. Allergy Clin. Immunol., 2014, 69: 246-253.
76. Yadav M., Mittal K., Effect of vitamin D supplementation on moderate to severe bronchial asthma, Indian J. Pediatr., 2014, 81 (7): 650-654.
77. Majak P., Rychlik B., Stelmach I., The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children, Clin. Exp. Allergy, 2009, 39 (12): 1830-1841.
78. De Groot J.C., Van Roon E.N.H., Storm H. y cols., Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma, J. Allergy Clin. Immunol., 2015, 135: 670-675.e3.
79. Martineau A.R., MacLaughlin B.D., Hooper R.L. y cols., Double-blind randomised placebo- controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs), Thorax, 2015, 70 (5): 451-457.
80. Castro M., King T.S., Kunselman S.J. y cols., Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels, JAMA, 2014, 311 (20): 2083.
81. Worth H., Stammen D., Keck E. Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D and a diphophonate, Am. J. Respir. Crit. Care Med., 1994, 150 (2): 394-397.
82. Martineau A., Cates C., Urashima M. y cols., Vitamin D for the management of asthma, Cochrane Database Syst. Rev., 2016, 9.
83. Lewis E., Fernandez C., Nella A. y cols., Relationship of 25-hydroxyvitamin D and asthma control in children, Ann. Allergy Asthma Immunol., 2012, 108 (4): 281-282.
84. Tachimoto H., Mezawa H., Segawa T. y cols., Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial, Allergy, 2016, 71 (7): 1001-1009.
85. Urashima M., Segawa T., Okazaki M. y cols., Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, Am. J. Clin. Nutr., 2010, 91 (5): 1255-1260.
86. Majak P., Olszowiec-Chlebna M., Smejda K. y cols., Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection, J. Allergy Clin. Immunol., 2011, 127 (5): 1294-1296.
87. Jensen M.E., Mailhot G., Alos N. y cols., Vitamin D intervention in preschoolers with viral-induced asthma (DIVA). A pilot randomised controlled trial, Trials, 2016, 17 (1): 353.
88. Boonpiyathad T., Chantveerawong T., Pradubpongsa P. y cols., Serum Vitamin D Levels and Vitamin D Supplement in Adult Patients with Asthma Exacerbation, J. Allergy, 2016, 1-9.
89. Ali A.M., Selim S., Abbassi M.M. y cols., Effect of alfacalcidol on the pulmonary function of adult asthmatic patients. A randomized trial, Ann. Allergy Asthma Immunol., 2017, 118 (5): 557-563.
90. Jolliffe D.A., Greenberg L., Hooper R.L. y cols., Vitamin D supplementation to prevent asthma exacerbations. Systematic review and meta-analysis of individual participant data, Lancet Respir. Med., 2017, 356 (i6583): 1-14.
91. Kerley C.P., Hutchinson K., Cormican L. y cols., Vitamin D3 for uncontrolled childhood asthma. A pilot study, Pediatr. Allergy Immunol., 2016, 27 (4): 404-412.
92. Chawes B.L., Bonnelykke K., Stokholm J. y cols., Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring, JAMA, 2016, 315 (4): 353.
93. Litonjua A.A., Carey V.J., Laranjo N. y cols., Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years, JAMA, 2016, 315 (4): 362, http: //
94. von Mutius E., Martinez F.D., Inconclusive Results of Randomized Trials of Prenatal Vitamin D for Asthma Prevention in Offspring: Curbing the Enthusiasm, JAMA, 2016, 315 (4): 347-348.
95. Calton E.K., Keane K.N., Newsholme P. y cols., The impact of Vitamin D levels on inflammatory status. A systematic review of immune cell studies, PLoS One, 2015, 10 (11): 1-12.
96. Mehta A.A., Agrawal A.D., Appanna V. y cols., Vitamin D improves corticosteroid efficacy and attenuates its side-effects in an animal model of asthma, Can. J. Physiol. Pharmacol., 2015, 93 (1): 53-61.
97. Huff G.R., Huff W.E., Balog J.M. y cols., Effect of dietary supplementation with vitamin D metabolites in an experimental model of turkey osteomyelitis complex, Poult. Sci., 2002, 81 (7): 958-965.